Close Menu

Small Wins Big

This week, The Scientist ranks readers' picks for the top 40 places to work in industry in 2011. Notably, the top three firms overall are each staffed by no more than 100 employees. This year, Epizyme — the Cambridge, Mass.-based drug-development company, which has fewer than 50 employees — takes top honors. The Scientist notes the firm's "integrity" and "communications" as its greatest strengths.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.